MedTrace Logo

Continuous Use of COCs

NCT00570440 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 362

Last updated 2011-10-31

No results posted yet for this study

Summary

The primary objective is to determine if continuous COC use leads to higher continuation rates over 12 months of follow up than use of the standard 28-day COC regimen.

Conditions

  • Pregnancy Prevention

Interventions

DRUG

Oral contraceptives--ethinyl estradiol, levonorgestrel

3 visits - screening/enrollment, 6-months and 12 months

Sponsors & Collaborators

  • La Asociación Pro Bienestar de la Familia de Guatemala (APROFAM)

    collaborator OTHER

  • FHI 360

    lead OTHER

Principal Investigators

  • Kavita Nanda, MD, MHS · FHI 360

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Dominican Republic
  • Nicaragua

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00570440 on ClinicalTrials.gov